Target type: biologicalprocess
Any process that increases appetite. [GOC:add]
Positive regulation of appetite is a complex biological process that involves multiple signaling pathways and neuronal circuits within the brain. It is tightly regulated by a variety of internal and external factors, including hormonal signals, nutrient availability, and environmental cues.
**Key Players and Mechanisms:**
**1. Hypothalamus:** The hypothalamus, a region in the brain, plays a central role in appetite regulation. Two key areas within the hypothalamus are:
* **Arcuate Nucleus:** This area contains neurons that produce neuropeptides involved in appetite regulation:
* **Neuropeptide Y (NPY) and Agouti-related protein (AgRP):** Stimulate appetite and promote food intake.
* **Pro-opiomelanocortin (POMC):** Suppresses appetite and promotes satiety.
* **Lateral Hypothalamic Area (LHA):** Contains neurons that promote feeding behavior.
**2. Hormones:**
* **Leptin:** Secreted by adipose (fat) tissue, leptin acts on the hypothalamus to suppress appetite and increase energy expenditure.
* **Insulin:** Released by the pancreas, insulin also acts on the hypothalamus to reduce appetite.
* **Ghrelin:** Produced in the stomach, ghrelin stimulates appetite and promotes food intake.
* **Cholecystokinin (CCK):** Secreted by the small intestine, CCK signals satiety (feeling full) and reduces appetite.
* **Glucagon-like peptide-1 (GLP-1):** Released by the gut in response to food intake, GLP-1 promotes satiety and slows gastric emptying.
**3. Neural Circuits:**
* **Reward Pathways:** Signals from the hypothalamus interact with the brain's reward system, influencing the pleasure derived from food intake.
* **Cognitive and Emotional Factors:** Higher brain regions like the prefrontal cortex and amygdala contribute to appetite regulation by processing food cues, memories, and emotional states.
**How It Works:**
1. **Hunger Signals:** When the body is in a state of energy deficiency, signals like ghrelin are released, stimulating the NPY/AgRP neurons in the arcuate nucleus. This leads to increased appetite and a drive to eat.
2. **Satiety Signals:** As food is consumed, signals like leptin, insulin, and CCK are released, suppressing the NPY/AgRP neurons and activating the POMC neurons. This promotes a feeling of fullness and reduces appetite.
3. **Integration and Modulation:** The hypothalamus integrates signals from various sources, including hormones, nutrient levels, and environmental cues, to fine-tune appetite regulation.
4. **Regulation of Energy Balance:** The positive regulation of appetite is essential for maintaining energy balance and ensuring sufficient energy intake to meet the body's needs.
**Factors Influencing Appetite:**
* **Nutrient Deficiency:** Low levels of essential nutrients can trigger increased appetite to replenish stores.
* **Stress:** Stress can disrupt appetite regulation, sometimes leading to overeating or undereating.
* **Sleep Deprivation:** Lack of sleep can increase levels of ghrelin and decrease leptin sensitivity, leading to increased appetite.
* **Food Availability and Variety:** The availability and palatability of food can significantly influence appetite and food intake.
**Disorders of Appetite Regulation:**
* **Obesity:** Characterized by excessive body fat accumulation, often due to a chronic imbalance between energy intake and expenditure.
* **Anorexia Nervosa:** An eating disorder characterized by an intense fear of gaining weight and severe food restriction.
* **Bulimia Nervosa:** An eating disorder characterized by recurrent episodes of binge eating followed by purging behaviors (vomiting, laxative use).
**Positive regulation of appetite is a dynamic and complex process that is essential for maintaining health and well-being. Understanding the mechanisms involved in appetite regulation is crucial for developing effective strategies for managing eating disorders, obesity, and other health conditions related to food intake.**'"
Protein | Definition | Taxonomy |
---|---|---|
Fatty acid synthase | A fatty acid synthase that is encoded in the genome of chicken. [OMA:P12276, PRO:DNx] | Gallus gallus (chicken) |
Growth hormone secretagogue receptor type 1 | A growth hormone secretagogue receptor that is encoded in the genome of human. [PRO:WCB, UniProtKB:Q92847] | Homo sapiens (human) |
Compound | Definition | Classes | Roles |
---|---|---|---|
dimethyl disulfide | organic disulfide | xenobiotic metabolite | |
diallyl trisulfide | organic trisulfide | anti-inflammatory agent; antilipemic drug; antineoplastic agent; antioxidant; antiprotozoal drug; apoptosis inducer; estrogen receptor antagonist; insecticide; platelet aggregation inhibitor; vasodilator agent | |
diallyl disulfide | diallyl disulfide : An organic disulfide where the organic group specified is allyl. It has been isolated from garlic and other species of the genus Allium. diallyl disulfide: major constituent of garlic oil | organic disulfide | antifungal agent; antineoplastic agent; plant metabolite |
substance p | peptide | neurokinin-1 receptor agonist; neurotransmitter; vasodilator agent | |
ursolic acid | hydroxy monocarboxylic acid; pentacyclic triterpenoid | geroprotector; plant metabolite | |
epigallocatechin gallate | (-)-epigallocatechin 3-gallate : A gallate ester obtained by the formal condensation of gallic acid with the (3R)-hydroxy group of (-)-epigallocatechin. epigallocatechin gallate: a steroid 5alpha-reductase inhibitor and antimutagen in green tea (Camellia sinensis) | flavans; gallate ester; polyphenol | antineoplastic agent; antioxidant; apoptosis inducer; geroprotector; Hsp90 inhibitor; neuroprotective agent; plant metabolite |
epicatechin gallate | (-)-epicatechin-3-O-gallate : A gallate ester obtained by formal condensation of the carboxy group of gallic acid with the (3R)-hydroxy group of epicatechin. A natural product found in Parapiptadenia rigida. epicatechin gallate: a steroid 5alpha-reductase inhibitor; RN given refers to the (cis)-isomer; structure given in first source; isolated from green tea | catechin; gallate ester; polyphenol | EC 3.2.1.1 (alpha-amylase) inhibitor; EC 3.2.1.20 (alpha-glucosidase) inhibitor; metabolite |
l 692429 | L 692429: stimulates release of growth hormone; RN refers to (R)-isomer; structure given in first source | ||
l 163191 | |||
cp 424391 | CP 424391: a growth hormone secretagogue; structure in first source | ||
luteolin | 3'-hydroxyflavonoid; tetrahydroxyflavone | angiogenesis inhibitor; anti-inflammatory agent; antineoplastic agent; apoptosis inducer; c-Jun N-terminal kinase inhibitor; EC 2.3.1.85 (fatty acid synthase) inhibitor; immunomodulator; nephroprotective agent; plant metabolite; radical scavenger; vascular endothelial growth factor receptor antagonist | |
ginkgolic acid | hydroxybenzoic acid | ||
cerulenin | cerulenin : An epoxydodecadienamide isolated from several species, including Acremonium, Acrocylindrum and Helicoceras. It inhibits the biosynthesis of several lipids by interfering with enzyme function. Cerulenin: An epoxydodecadienamide isolated from several species, including ACREMONIUM, Acrocylindrum, and Helicoceras. It inhibits the biosynthesis of several lipids by interfering with enzyme function. | epoxide; monocarboxylic acid amide | antifungal agent; antiinfective agent; antilipemic drug; antimetabolite; antimicrobial agent; fatty acid synthesis inhibitor |
avicularin | avicularin : A quercetin O-glycoside in which an alpha-L-arabinofuranosyl residue is attached at position 3 of quercetin via a glycosidic linkage. It is isolated particularly from Juglans regia and Foeniculum vulgare. avicularin: from Polygonum aviculare L.; RN given refers to L-isomer | alpha-L-arabinofuranoside; monosaccharide derivative; quercetin O-glycoside; tetrahydroxyflavone | hepatoprotective agent; plant metabolite |
hexarelin | hexarelin: a synthetic growth hormone releasing peptide; structurally similar to GHRP-6, with the substitution of D-Trp with its 2-methyl derivative; more potent & stable and less toxic than GHRP-6 | ||
sm 130686 | SM 130686: a growth hormone secretagogue; structure in first source | ||
macimorelin | |||
tabimorelin | tabimorelin: a growth hormone secretagogue; structure in first source | ||
4-methylene-2-octyl-5-oxofuran-3-carboxylic acid | (2R,3S)-C75 : A 4-methylidene-2-octyl-5-oxotetrahydrofuran-3-carboxylic acid that has 2R,3S-configuration. 4-methylene-2-octyl-5-oxofuran-3-carboxylic acid: an anorectic fatty acid synthase inhibitor; structure in first source | 4-methylidene-2-octyl-5-oxotetrahydrofuran-3-carboxylic acid; gamma-lactone | |
l 162752 | |||
sk&f 110679 | |||
ulimorelin | ulimorelin: ghrelin agonist; an 18-membered macrocycle containing 3 amide bonds and a secondary amine as well as 4 stereogenic centers; belongs to macrocyclic peptidomimetics | oligopeptide | |
n-(3-fluorophenyl)-1-((4-(((3s)-3-methyl-1-piperazinyl)methyl)phenyl)acetyl)-4-piperidinamine | N-(3-fluorophenyl)-1-((4-(((3S)-3-methyl-1-piperazinyl)methyl)phenyl)acetyl)-4-piperidinamine: a small molecule motilin receptor agonist; structure in first source | acetamides | |
yil 781 | YIL 781: an appetite suppressant and weight loss promoter; structure in first source | ||
nitd 609 | NITD 609: an antimalarial and coccidiostat; structure in first source | ||
gsk 2334470 | GSK 2334470: a PDK1 inhibitor; structure in first source | indazoles |